Insider · CIK 0001308428
Kieran Gallahue
Files at EW (Edwards Lifesciences Corp), NVST (Envista Holdings Corp). First filing Feb 26, 2024, latest Feb 26, 2024.
In brief
Kieran Gallahue files SEC Form 4 as director at EW (Edwards Lifesciences Corp), and also at NVST (Envista Holdings Corp). Since Feb 26, 2024, Kieran Gallahue has reported 0 open-market buys worth $0 and 1 open-market sell worth $268k, the latest filed on Feb 26, 2024.
A track record needs three past buys with six months of prices behind them; Kieran Gallahue has 0, so none is measured yet.
The newest scored trade: sold $268k of EW on Feb 23, 2024, filed Feb 26, 2024, scored 28 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EW: Edwards Lifesciences Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Edwards Lifesciences Corp | $268k 3,058 shares | -4% | +42% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 23, 2024 | EW Edwards Lifesciences Corp | 3,058 0.00% of outstanding | $268k | Feb 23, 2024 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | NVST Envista Holdings Corp | AGrant or award Common Stock | +9,330 | $0.00 | $0 | 54,010 | May 21, 2026 |
| May 8, 2026 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +3,251 | $0.00 | $0 | 3,251 | May 8, 2026 |
| May 8, 2026 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +1,064 | $0.00 | $0 | 4,315 | May 8, 2026 |
| Jun 10, 2025 | NVST Envista Holdings Corp | AGrant or award Common Stock | +10,450 | $0.00 | $0 | 44,680 | Jun 12, 2025 |
| May 9, 2025 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +3,528 | $0.00 | $0 | 3,528 | May 9, 2025 |
| May 9, 2025 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +1,154 | $0.00 | $0 | 4,682 | May 9, 2025 |
| Feb 23, 2024 | EW Edwards Lifesciences Corp | MOption exercise Common Stock | +7,056 | $36.86 | $260k | 10,757 | Feb 26, 2024 |
| Feb 23, 2024 | EW Edwards Lifesciences Corp | GGift Common Stock | -7,056 | $0.00 | $0 | 3,701 | Feb 26, 2024 |
| Feb 23, 2024 | EW Edwards Lifesciences Corp | GGift Common Stockindirect: By Trust | +7,056 | $0.00 | $0 | 70,277 | Feb 26, 2024 |
| Feb 23, 2024 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stockindirect: By Trust | -3,058 | $87.61 | $268k | 67,219 | Feb 26, 2024 |
| Feb 23, 2024 | EW Edwards Lifesciences Corp | MOption exercise Director Stock Option (Right to Acquire)derivative | -7,056 | $0.00 | $0 | 0 | Feb 26, 2024 |
Questions about Kieran Gallahue
Answered from the filings on this page, as of the latest one.
Is Kieran Gallahue buying or selling?
Not in the last 12 months. Kieran Gallahue's latest open-market trade on SEC Form 4 was sold $268k of EW on Feb 23, 2024.
How did Kieran Gallahue's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kieran Gallahue has 0.
Where does Kieran Gallahue file Form 4?
Kieran Gallahue has filed Form 4 at EW (Edwards Lifesciences Corp); NVST (Envista Holdings Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.